Morristown nonprofit calls AHCA ‘death sentence’ for HIV patients; urges support for AIDS Walk, May 7 according to : morristowngreen

"We have never needed the community's support more," said Joann McEniry, chief operating officer of New Jersey AIDS Services, which organizes and hosts the walk's Morristown location. By Morristown Green Contributor -From New Jersey AIDS Services. Join us in fighting this pandemic by walking with us in the 2017 New Jersey AIDS Walk on Sunday May 7th. The New Jersey AIDS Walk will be held this Sunday, May 7, 2017. The legislation is eerily familiar to the inaccessible health care of the 80's/90's that lead to the death of millions.




In Brief Researchers have discovered that post-transplant donor cells trigger a potentially fatal immune system war, graft-versus-host disease, that may wipe out HIV. New Insight Into HIVSo, does this mean that doctors will induce an immune system war in patients intentionally, with the hopes that they'll live and be cured? Current research suggests that the cure might be the aftermath of an immune system war that the transplant cells triggered within his body — a war he survived, but the virus didn't. In Brown's case, the healthier donor cells won, killing not just the immune response in his cells, but also the HIV virus that lived there. If they're right, knowing how the disease finds where HIV hides may lead to a cure.

Tesamorelin May Reduce Insulin Resistance in HIV With Lipodystrophy

Tesamorelin May Reduce Insulin Resistance in HIV With LipodystrophyShare this content:linkedingoogleEmailPrintPositive associations noted in fasting blood glucose, fasting insulin, and HOMA-IR. "Changes in liver transaminases were associated with changes in glucose parameters and adiponectin in tesamorelin responders," the researchers concluded. Continue Reading BelowTesamorelin is a stabilized analogue of human growth-releasing hormone that has been previously shown to reduce VAT in patients who are HIV positive with lipodystrophy. Association of changes in liver transaminases with changes in glucose parameters and adiponectin in HIV-infected patients treated with tesamorelin, a growth hormone-releasing hormone analogue. Liver damage in patients with HIV and abdominal fat is associated with insulin resistance, according to research presented at the 26th Annual American Association of Clinical Endocrinologists (AACE) Scientific & Clinical Congress, May 3-7, 2017, in Austin, TX.